Bingfan Du

Identification of a Potent, State-Dependent Inhibitor of Nav1.7 with Oral Efficacy in the Formalin Model of Persistent Pain

Howard Bregman, Loren Berry, John L. Buchanan et al. · Journal of Medicinal Chemistry · 2011 · 54 citations · Full text

Discovery of <i>N</i>-(4-(3-(2-Aminopyrimidin-4-yl)pyridin-2-yloxy)phenyl)-4-(4-methylthiophen-2-yl)phthalazin-1-amine (AMG 900), A Highly Selective, Orally Bioavailable Inhibitor of Aurora Kinases with Activity against Multidrug-Resistant Cancer Cell Lines

Stephanie Geuns-Meyer, Victor J. Cee, Holly L. Deak et al. · Journal of Medicinal Chemistry · 2015 · 44 citations · Full text

Pharmacotherapy, Pharmaceutical Chemistry, Tumor Biology +19

Sulfonamides as Selective Na_V1.7 Inhibitors: Optimizing Potency and Pharmacokinetics to Enable in Vivo Target Engagement

Isaac E. Marx, Thomas A. Dineen, Jessica Able et al. · ACS Medicinal Chemistry Letters · 2016 · 37 citations · Full text

Antifungal activity of a series of 1,2-benzisothiazol-3(2H)-one derivatives

Dengfeng Dou, Deepu Alex, Bingfan Du et al. · Bioorganic & Medicinal Chemistry · 2011 · 36 citations

Antifungal Agent, Antifungal Activity, Antifungal Agents +3

Synthesis of 4-Substituted Chlorophthalazines, Dihydrobenzoazepinediones, 2-Pyrazolylbenzoic Acid, and 2-Pyrazolylbenzohydrazide via 3-Substituted 3-Hydroxyisoindolin-1-ones

Hanh Nho Nguyen, Victor J. Cee, Holly L. Deak et al. · The Journal of Organic Chemistry · 2012 · 34 citations

Heterocyclic, 4-Substituted Chlorophthalazines, 2-Pyrazolylbenzoic Acid +9